<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Augmented curation of the unstructured clinical notes from the EHR reveals specific clinically confirmed phenotypes that are amplified in COVID<italic><sub>pos</sub></italic> patients over COVID<italic><sub>neg</sub></italic> patients in the week prior to the SARS-CoV-2 PCR testing date.</title><p>The key COVID<italic><sub>pos</sub></italic> amplified symptoms in the week preceding PCR testing (i.e. day = &#8722;7 to day = &#8722;1) are highlighted in gray (p-value&lt;1E-10). The ratio of COVID<italic><sub>pos</sub></italic> to COVID<italic><sub>neg</sub></italic> proportions represents the fold change amplification of each phenotype in the COVID<italic><sub>pos</sub></italic> patient set (symptoms are sorted based on this column).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Symptom <break/>(<italic>p-value&lt;1E-10 in gray</italic>)</th><th valign="top">COVID+ <break/>Count (%) (N&#160;=&#160;2317)</th><th valign="top">COVID- <break/>Count (%) <break/>(N&#160;=&#160;74850)</th><th valign="top">(COVID+/COVID-) Relative Ratio</th><th valign="top">Relative ratio <break/>(95% CI)</th><th valign="top">2-tailed p-value</th><th valign="top">BH-corrected p-value</th></tr></thead><tbody><tr><td style="author-callout-style-b8" valign="bottom">Altered or diminished sense of taste or smell</td><td valign="bottom">145 (6.3%)</td><td valign="bottom">173 (0.2%)</td><td valign="bottom">27.08</td><td valign="top">(21.81, 33.62)</td><td valign="top">&lt;1E-300</td><td valign="top">&lt;1E-300</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Fever/chills</td><td valign="bottom">750 (32.4%)</td><td valign="bottom">9421 (12.6%)</td><td valign="bottom">2.57</td><td valign="top">(2.42, 2.74)</td><td valign="top">3.57E-169</td><td valign="top">4.64E-168</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Cough</td><td valign="bottom">769 (33.2%)</td><td valign="bottom">11083 (14.8%)</td><td valign="bottom">2.24</td><td valign="top">(2.11, 2.38)</td><td valign="top">4.60E-129</td><td valign="top">3.99E-128</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Respiratory difficulty</td><td valign="bottom">681 (29.4%)</td><td valign="bottom">10082 (13.5%)</td><td valign="bottom">2.18</td><td valign="top">(2.04, 2.33)</td><td valign="top">3.06E-105</td><td valign="top">1.99E-104</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Myalgia/Arthralgia</td><td valign="bottom">288 (12.4%)</td><td valign="bottom">4620 (6.2%)</td><td valign="bottom">2.01</td><td valign="top">(1.8, 2.25)</td><td valign="top">5.35E-34</td><td valign="top">2.78E-33</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Rhinitis</td><td valign="bottom">200 (8.6%)</td><td valign="bottom">2947 (3.9%)</td><td valign="bottom">2.19</td><td valign="top">(1.92, 2.52)</td><td valign="top">2.25E-29</td><td valign="top">9.75E-29</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Headache</td><td valign="bottom">325 (14.0%)</td><td valign="bottom">6124 (8.2%)</td><td valign="bottom">1.71</td><td valign="top">(1.55, 1.9)</td><td valign="top">1.34E-23</td><td valign="top">4.98E-23</td></tr><tr><td style="author-callout-style-b8" valign="bottom">Congestion</td><td valign="bottom">228 (9.8%)</td><td valign="bottom">4261 (5.7%)</td><td valign="bottom">1.73</td><td valign="top">(1.53, 1.96)</td><td valign="top">4.45E-17</td><td valign="top">1.45E-16</td></tr><tr><td style="author-callout-style-b8" valign="bottom">GI upset</td><td valign="bottom">195 (8.4%)</td><td valign="bottom">10670 (14.3%)</td><td valign="bottom">0.59</td><td valign="top">(0.52, 0.68)</td><td valign="top">1.74E-15</td><td valign="top">5.03E-15</td></tr><tr><td valign="bottom">Wheezing</td><td valign="bottom">49 (2.1%)</td><td valign="bottom">3765 (5.0%)</td><td valign="bottom">0.42</td><td valign="top">(0.32, 0.56)</td><td valign="top">1.82E-10</td><td valign="top">4.73E-10</td></tr><tr><td valign="bottom">Dermatitis</td><td valign="bottom">26 (1.1%)</td><td valign="bottom">2519 (3.4%)</td><td valign="bottom">0.33</td><td valign="top">(0.23, 0.5)</td><td valign="top">2.60E-09</td><td valign="top">6.15E-09</td></tr><tr><td valign="bottom">Generalized symptoms</td><td valign="bottom">169 (7.3%)</td><td valign="bottom">8129 (10.9%)</td><td valign="bottom">0.67</td><td valign="top">(0.58, 0.78)</td><td valign="top">4.82E-08</td><td valign="top">1.04E-07</td></tr><tr><td valign="top">Respiratory Failure</td><td valign="top">73 (3.2%)</td><td valign="top">1363 (1.8%)</td><td valign="top">1.73</td><td valign="top">(1.38, 2.19)</td><td valign="top">3.09E-06</td><td valign="top">6.18E-06</td></tr><tr><td valign="bottom">Diarrhea</td><td valign="bottom">228 (9.8%)</td><td valign="bottom">5452 (7.3%)</td><td valign="bottom">1.35</td><td valign="top">(1.19, 1.53)</td><td valign="top">3.47E-06</td><td valign="top">6.44E-06</td></tr><tr><td valign="bottom">Pharyngitis</td><td valign="bottom">160 (6.9%)</td><td valign="bottom">3635 (4.9%)</td><td valign="bottom">1.42</td><td valign="top">(1.22, 1.66)</td><td valign="top">7.05E-06</td><td valign="top">1.22E-05</td></tr><tr><td valign="bottom">Chest pain/pressure</td><td valign="bottom">148 (6.4%)</td><td valign="bottom">6122 (8.2%)</td><td valign="bottom">0.78</td><td valign="top">(0.67, 0.92)</td><td valign="top">1.88E-03</td><td valign="top">3.06E-03</td></tr><tr><td valign="bottom">Change in appetite/intake</td><td valign="bottom">95 (4.1%)</td><td valign="bottom">2271 (3.0%)</td><td valign="bottom">1.35</td><td valign="top">(1.11, 1.66)</td><td valign="top">3.37E-03</td><td valign="top">5.15E-03</td></tr><tr><td valign="bottom">Otitis</td><td valign="bottom">13 (0.6%)</td><td valign="bottom">874 (1.2%)</td><td valign="bottom">0.48</td><td valign="top">(0.29, 0.85)</td><td valign="top">6.98E-03</td><td valign="top">1.01E-02</td></tr><tr><td valign="bottom">Cardiac</td><td valign="bottom">95 (4.1%)</td><td valign="bottom">2443 (3.3%)</td><td valign="bottom">1.26</td><td valign="top">(1.03, 1.54)</td><td valign="top">2.62E-02</td><td valign="top">3.59E-02</td></tr><tr><td valign="bottom">Fatigue</td><td valign="bottom">229 (9.9%)</td><td valign="bottom">8268 (11.0%)</td><td valign="bottom">0.89</td><td valign="top">(0.79, 1.02)</td><td valign="top">7.83E-02</td><td valign="top">1.02E-01</td></tr><tr><td valign="bottom">Conjunctivitis</td><td valign="bottom">9 (0.4%)</td><td valign="bottom">167 (0.2%)</td><td valign="bottom">1.74</td><td valign="top">(0.95, 3.52)</td><td valign="top">1.00E-01</td><td valign="top">1.24E-01</td></tr><tr><td valign="bottom">Dry mouth</td><td valign="bottom">5 (0.2%)</td><td valign="bottom">316 (0.4%)</td><td valign="bottom">0.51</td><td valign="top">(0.24, 1.3)</td><td valign="top">1.28E-01</td><td valign="top">1.51E-01</td></tr><tr><td valign="bottom">Hemoptysis</td><td valign="bottom">13 (0.6%)</td><td valign="bottom">283 (0.4%)</td><td valign="bottom">1.48</td><td valign="top">(0.89, 2.65)</td><td valign="top">1.61E-01</td><td valign="top">1.78E-01</td></tr><tr><td valign="top">Dysuria</td><td valign="top">16 (0.7%)</td><td valign="top">732 (1.0%)</td><td valign="top">0.71</td><td valign="top">(0.45, 1.18)</td><td valign="top">1.64E-01</td><td valign="top">1.78E-01</td></tr><tr><td valign="bottom">Diaphoresis</td><td valign="bottom">35 (1.5%)</td><td valign="bottom">979 (1.3%)</td><td valign="bottom">1.15</td><td valign="top">(0.84, 1.63)</td><td valign="top">3.99E-01</td><td valign="top">4.15E-01</td></tr><tr><td valign="bottom">Neuro</td><td valign="bottom">150 (6.5%)</td><td valign="bottom">4952 (6.6%)</td><td valign="bottom">0.98</td><td valign="top">(0.84, 1.15)</td><td valign="top">7.86E-01</td><td valign="top">7.86E-01</td></tr></tbody></table></table-wrap>